Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression

Abstract

Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes.